| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $9.9M | -23.8% |
| SG&A Expense | $6.8M | +115.5% |
| Operating Income | -$16.7M | -3.4% |
| Pre-tax Income | -$13.7M | +12.0% |
| Income Tax | $800 | +0.0% |
| Net Income | -$13.7M | +12.0% |
| EPS (Basic) | -$1.85 | +55.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $61.8M | +35.0% |
| Current Assets | $140.5M | +133.0% |
| Total Assets | $140.7M | +133.4% |
| Current Liabilities | $2.7M | -47.9% |
| Total Liabilities | $2.9M | -45.0% |
| Stockholders' Equity | $137.8M | +150.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$12.2M | -90.5% |
| Investing Cash Flow | -$63.5M | -342.5% |
| Financing Cash Flow | $91.6M | +54.4% |